The Journal of Immunology, Vol 157, Issue 6 2618-2623, Copyright © 1996 by American Association of Immunologists

ARTICLES

IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells

E Giraudo, M Arese, C Toniatti, M Strasly, L Primo, A Mantovani, G Ciliberto and F Bussolini
Department of Genetics, Biological and Medical Chemistry, University of Torino, Italy.

Murine endothelial cells immortalized with the middle-size Ag of polyomavirus (PmT) cause vascular tumors in syngenic mice by recruitment of host normal endothelial cells. This pathogenic process is similar to that occurring in Kaposi's sarcoma, in which the core of the lesion is constituted by "spindle cells," which recruit normal vascular mesenchymal cells. In murine endothelial cells, PmT induces modification of the expression of genes, including that of IL-6. Since IL-6 is a pleiotrophic cytokine that also regulates endothelial cell functions related to angiogenesis, we studied the relevance of IL-6 in the tumorigenicity of PmT-endothelial cells. In vitro studies demonstrated that the spontaneous PmT-endothelial cell proliferation rate was slow during the first 6 days of culture and then increased rapidly and paralleled the IL-6 release. The addition of recombinant IL- 6 during the first days of culture induced a marked proliferation in a dose-dependent manner. PmT-endothelial cells expressed on their surface a high-affinity binding site for IL-6 constituted by both IL-6Ralpha and gp130 transmembrane receptors. The growth-promoting effect of exogenous IL-6 or that released by PmT-endothelial cells was abrogated by mAbs anti-IL-6Ralpha, whereas a mAb recognizing the endothelial cell CD31 molecule was inactive. 15A7 mAb anti-murine IL-6Ralpha was also active in vivo, reducing the number of metastases forming after transplantation of PmT-endothelial cells in DBA/2 mice. 15A7 mAb also increased the survival of mice bearing vascular tumors. We conclude that IL-6 is involved in the progression of vascular tumors induced by PmT, and that the blockage of IL-6-mediated intercellular circuits could be useful in the management of human vascular tumors, including Kaposi's sarcoma.

This article has been cited by other articles:

				L. Chen, X. Wang, and M. M. Fluck Independent contributions of polyomavirus middle T and small T to the regulation of early and late gene expression and DNA replication. J. Virol., August 1, 2006; 80(15): 7295 - 7307. [Abstract] [Full Text] [PDF]

				A. Turturro, P. Duffy, B. Hass, R. Kodell, and R. Hart Survival Characteristics and Age-Adjusted Disease Incidences in C57BL/6 Mice Fed a Commonly Used Cereal-Based Diet Modulated by Dietary Restriction J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2002; 57(11): B379 - 389. [Abstract] [Full Text] [PDF]

				M. Strasly, F. Cavallo, M. Geuna, S. Mitola, M. P. Colombo, G. Forni, and F. Bussolino IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk J. Immunol., March 15, 2001; 166(6): 3890 - 3899. [Abstract] [Full Text] [PDF]

				D. I. Lebovic, F. Bentzien, V. A. Chao, E. N. Garrett, Y.G. Meng, and R. N. Taylor Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1{beta} Mol. Hum. Reprod., March 1, 2000; 6(3): 269 - 275. [Abstract] [Full Text] [PDF]

				A. C. La Flamme, A. S. MacDonald, and E. J. Pearce Role of IL-6 in Directing the Initial Immune Response to Schistosome Eggs J. Immunol., March 1, 2000; 164(5): 2419 - 2426. [Abstract] [Full Text] [PDF]

				H Paradis and R. Gendron LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase J. Cell Sci., January 12, 2000; 113(23): 4331 - 4339. [Abstract] [PDF]

				K.-H. Chen, C.-C. Wu, S. Roy, S.-M. Lee, and J.-H. Liu Increased Interleukin-6 in Aqueous Humor of Neovascular Glaucoma Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2627 - 2632. [Abstract] [Full Text] [PDF]

				M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria Oncostatin M Induces Angiogenesis In Vitro and In Vivo Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1835 - 1842. [Abstract] [Full Text] [PDF]

				A. C. La Flamme and E. J. Pearce The Absence of IL-6 Does Not Affect Th2 Cell Development In Vivo, But Does Lead to Impaired Proliferation, IL-2 Receptor Expression, and B Cell Responses J. Immunol., May 15, 1999; 162(10): 5829 - 5837. [Abstract] [Full Text] [PDF]

				L. Biancone, I. Stamenkovic, V. Cantaluppi, M. Boccellino, A. De Martino, F. Bussolino, and G. Camussi Expression of L-Selectin Ligands by Transformed Endothelial Cells Enhances T Cell-Mediated Rejection J. Immunol., May 1, 1999; 162(9): 5263 - 5269. [Abstract] [Full Text] [PDF]

				D. Ribatti, M. Presta, A. Vacca, R. Ria, R. Giuliani, P. Dell'Era, B. Nico, L. Roncali, and F. Dammacco Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo Blood, April 15, 1999; 93(8): 2627 - 2636. [Abstract] [Full Text] [PDF]

				T. Alonzi, E. Fattori, D. Lazzaro, P. Costa, L. Probert, G. Kollias, F. De Benedetti, V. Poli, and G. Ciliberto Interleukin 6 Is Required for the Development of Collagen-induced Arthritis J. Exp. Med., February 16, 1998; 187(4): 461 - 468. [Abstract] [Full Text] [PDF]